ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered donor cells aim to beat blood cancer without severe side effects
Disease control OngoingThis study tests a new way to treat children and young adults with high-risk blood cancers like leukemia and lymphoma. Doctors take blood cells from a family donor, remove certain T cells that can cause a harmful immune reaction, and then transplant the modified cells. The goal i…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for kids with relapsed leukemia: early trial combines three drugs
Disease control OngoingThis early-phase trial tests a combination of three drugs—ribociclib, everolimus, and dexamethasone—in children and young adults (ages 1 to 30) whose acute lymphoblastic leukemia has come back or not responded to standard treatment. The main goal is to find the safest dose and un…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC